Genpharmasec Limited has formed a new wholly owned subsidiary company namely Clinigenome India Private Limited. The Authorised Share capital of the Company is 200,000 Equity Shares of INR 10/each-The paid-up capital of the company is INR 100,000/- divided in to 10,000 Equity Shares of INR 10 each. The main objects of Clinigenome India Private Limited as per its MOA is of: To carry on the business of specialized testing centre dedicated to providing high quality molecular testing at affordable price and to promote, establish, maintain, conduct and run testing laboratory, research laboratory, experimental workshops, scientific laboratory, examination, analysis, investigations, test, experiment & research on behalf of government, semi government, local authorities, private bodies and general public for all kinds of materials, including pharmaceuticals, drugs, chemicals, medical, metallurgical, electronic, cement, electrical, agricultural, edibles, and other items of industrial, domestic or commercial use and to buy, sell, import, export, consign, store, clean, recondition & develop or otherwise to deal in all types of intermediates, chemicals, instruments, equipment, apparatuses, accessories, fittings, goods, articles or things which are required for the attainment of the above objects and to provide cargo inspection, survey, sampling facility for export material and insurance purposes.

The Company is incorporated as wholly owned subsidiary of the company on 29th January 2024.